Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration

被引:238
作者
Shimbo, Keisuke [1 ]
Miyaki, Shigeru [1 ,2 ]
Ishitobi, Hiroyuki [2 ]
Kato, Yoshio [3 ]
Kubo, Tadahiko [1 ]
Shimose, Shoji [1 ]
Ochi, Mitsuo [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Hiroshima, Japan
[2] Hiroshima Univ Hosp, Dept Regenerat Med, Hiroshima, Japan
[3] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan
关键词
Exosome; miR-143; Osteosarcoma cells; Delivery system; MESENCHYMAL STEM-CELLS; CANCER-CELLS; DELIVERY; VESICLES; MECHANISM;
D O I
10.1016/j.bbrc.2014.02.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) have emerged as potential anticancer agents, but their clinical application is limited by the lack of an effective delivery system to tumors. Exosomes are small vesicles that play important roles in intercellular communication. Here, we show that synthetic miR-143 introduced into cells is released enveloped in exosomes and that the secreted exosome-formed miR-143 is transferred to osteosarcoma cells. The delivery of exosome-formed miR-143 significantly reduced the migration of osteosarcoma cells. The delivery efficiency of exosome-formed miR-143 was less than that achieved with lipofection, but the migratory potential of osteosarcoma cells was similarly inhibited after both strategies. Our results suggest that exosomes can deliver synthetic miR-143 and are a potentially efficient and functional delivery system. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:381 / 387
页数:7
相关论文
共 30 条
[11]  
Geller David S, 2010, Clin Adv Hematol Oncol, V8, P705
[12]   The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles [J].
Katsuda, Takeshi ;
Kosaka, Nobuyoshi ;
Takeshita, Fumitaka ;
Ochiya, Takahiro .
PROTEOMICS, 2013, 13 (10-11) :1637-1653
[13]   Osteosarcoma relapse after combined modality therapy:: An analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS) [J].
Kempf-Bielack, B ;
Bielack, SS ;
Jürgens, H ;
Branscheid, D ;
Berdel, WE ;
Exner, GU ;
Göbel, U ;
Helmke, K ;
Jundt, G ;
Kabisch, H ;
Kevric, M ;
Klingebiel, T ;
Kotz, R ;
Maas, R ;
Schwarz, R ;
Semik, M ;
Treuner, J ;
Zoubek, A ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) :559-568
[14]   Competitive Interactions of Cancer Cells and Normal Cells via Secretory MicroRNAs [J].
Kosaka, Nobuyoshi ;
Iguchi, Haruhisa ;
Yoshioka, Yusuke ;
Hagiwara, Keitaro ;
Takeshita, Fumitaka ;
Ochiya, Takahiro .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (02) :1397-1405
[15]   Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells [J].
Kosaka, Nobuyoshi ;
Iguchi, Haruhisa ;
Yoshioka, Yusuke ;
Takeshita, Fumitaka ;
Matsuki, Yasushi ;
Ochiya, Takahiro .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (23) :17442-17452
[16]   MicroRNAs: molecular features and role in cancer [J].
Lages, Elodie ;
Ipas, Helene ;
Guttin, Audrey ;
Nesr, Houssam ;
Berger, Francois ;
Issartel, Jean-Paul .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2012, 17 :2508-2540
[17]   Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal [J].
Lee, Hae Kyung ;
Finniss, Susan ;
Cazacu, Simona ;
Bucris, Efrat ;
Ziv-Av, Amotz ;
Xiang, Cunli ;
Bobbitt, Kevin ;
Rempel, Sandra A. ;
Hasselbach, Laura ;
Mikkelsen, Tom ;
Slavin, Shimon ;
Brodie, Chaya .
ONCOTARGET, 2013, 4 (02) :346-361
[18]   Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets [J].
Lewis, BP ;
Burge, CB ;
Bartel, DP .
CELL, 2005, 120 (01) :15-20
[19]   Toxicity of cationic lipids and cationic polymers in gene delivery [J].
Lv, Hongtao ;
Zhang, Shubiao ;
Wang, Bing ;
Cui, Shaohui ;
Yan, Jie .
JOURNAL OF CONTROLLED RELEASE, 2006, 114 (01) :100-109
[20]   Macro view of microRNA function in osteoarthritis [J].
Miyaki, Shigeru ;
Asahara, Hiroshi .
NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (09) :543-552